Joint (NASDAQ:JYNT) Rating Reiterated by Roth Mkm

Joint (NASDAQ:JYNT - Get Free Report)'s stock had its "buy" rating reaffirmed by investment analysts at Roth Mkm in a note issued to investors on Friday, Benzinga reports. They presently have a $16.00 price objective on the stock, up from their prior price objective of $13.00. Roth Mkm's price target suggests a potential downside of 0.74% from the company's previous close.

Separately, TheStreet downgraded Joint from a "c-" rating to a "d" rating in a report on Thursday, March 7th. Three analysts have rated the stock with a hold rating and one has issued a buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $23.00.

Joint Trading Up 25.3 %

NASDAQ:JYNT traded up $3.26 during mid-day trading on Friday, reaching $16.12. 261,585 shares of the company's stock traded hands, compared to its average volume of 89,441. Joint has a 12-month low of $7.31 and a 12-month high of $16.43. The firm has a market capitalization of $240.77 million, a price-to-earnings ratio of -24.42 and a beta of 1.58. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.32 and a quick ratio of 1.32. The company has a 50 day moving average price of $12.05 and a 200-day moving average price of $10.14.

Joint (NASDAQ:JYNT - Get Free Report) last announced its quarterly earnings results on Thursday, March 7th. The company reported $0.07 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.03 by $0.04. Joint had a positive return on equity of 7.80% and a negative net margin of 8.19%. The company had revenue of $30.61 million for the quarter, compared to the consensus estimate of $29.63 million. On average, sell-side analysts predict that Joint will post 0.13 earnings per share for the current year.

Institutional Trading of Joint

Several large investors have recently bought and sold shares of the company. Hudson Bay Capital Management LP bought a new position in Joint during the 3rd quarter valued at approximately $867,000. WINTON GROUP Ltd bought a new position in shares of Joint during the third quarter valued at $179,000. First Foundation Advisors purchased a new position in shares of Joint in the 3rd quarter worth about $1,336,000. Trexquant Investment LP boosted its stake in Joint by 15.2% in the 3rd quarter. Trexquant Investment LP now owns 76,589 shares of the company's stock worth $689,000 after purchasing an additional 10,122 shares in the last quarter. Finally, Skylands Capital LLC grew its position in Joint by 20.3% during the 4th quarter. Skylands Capital LLC now owns 603,640 shares of the company's stock valued at $5,801,000 after purchasing an additional 101,850 shares during the last quarter. 76.88% of the stock is owned by institutional investors.

About Joint

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.